HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glycylproline 4-nitroanilidase

splits of glycylproline from p-nitroaniline

Also Known As:

GPNAase; glycylproline p-nitroanilidase

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Enzymes and Coenzymes: 1
- Enzymes: 152586
  - Hydrolases: 2166
    - Peptide Hydrolases: 23957
      - Exopeptidases: 68
        Dipeptidyl-Peptidases and Tripeptidyl-Peptidases: 379
        glycylproline 4-nitroanilidase: 5

Related Diseases

1.	Rheumatoid Arthritis 07/01/1978 - "Serum glycylproline p-nitroanilidase activity in rheumatoid arthritis." 08/15/1978 - "Glycylproline p-nitroanilidase activity in serum of patients with advanced rheumatoid arthritis or with systemic lupus erythematosus but with normal hepatic function was found to be significantly lower than that of normal adult controls. " 08/15/1978 - "Serum glycylproline p-nitroanilidase activity in rheumatoid arthritis and systemic lupus erythematosus."
2.	Essential Hypertension 01/17/1977 - "Glycylproline p-nitroanilidase activity in serum from patients with essential hypertension was significantly higher than that from normotensive healthy subjects. " 07/01/1979 - "We have studied serum glycyl-prolyl-p-nitroanilidase (GPNAase) activity and its distribution in various parts of the body in patients with acute myocardial infarction, chronic ischemic heart disease, valvular heart disease with or without congestive heart failure and essential hypertension. "
3.	Hematologic Neoplasms (Hematological Malignancy) 12/01/1977 - "Serum glycylproline p-nitroanilidase activity in blood cancers."
4.	Myocardial Ischemia (Ischemic Heart Diseases) 07/01/1979 - "We have studied serum glycyl-prolyl-p-nitroanilidase (GPNAase) activity and its distribution in various parts of the body in patients with acute myocardial infarction, chronic ischemic heart disease, valvular heart disease with or without congestive heart failure and essential hypertension. "
5.	Myocardial Infarction 07/01/1979 - "Serum GPNAase activity in patients with acute myocardial infarction was significantly lower as long as 12 days after the onset as compared with normal controls. " 07/01/1979 - "We have studied serum glycyl-prolyl-p-nitroanilidase (GPNAase) activity and its distribution in various parts of the body in patients with acute myocardial infarction, chronic ischemic heart disease, valvular heart disease with or without congestive heart failure and essential hypertension. "